Literature DB >> 20535620

Neuroinflammation in Huntington's disease.

Thomas Möller1.   

Abstract

Huntington's disease (HD) is a monogenic neurodegenerative disease characterized by abnormal motor movements, personality changes and early death. In contrast to other neurodegenerative diseases, very little is known about the role of neuroinflammation in HD. While the current data clearly demonstrate the existence of inflammatory processes in HD pathophysiology, the question of whether neuroinflammation is purely reactive or might actively participate in disease pathogenesis is currently a matter of ongoing research and debate. This review will try to shed some light on the current state of research in this area and provide an outlook on potential future developments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20535620     DOI: 10.1007/s00702-010-0430-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  104 in total

Review 1.  Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling.

Authors:  Sin-Hyeog Im; Anjana Rao
Journal:  Mol Cells       Date:  2004-08-31       Impact factor: 5.034

Review 2.  Microglia and neuroprotection: implications for Alzheimer's disease.

Authors:  Wolfgang J Streit
Journal:  Brain Res Brain Res Rev       Date:  2005-01-15

Review 3.  Huntington's Disease.

Authors:  Francis O Walker
Journal:  Semin Neurol       Date:  2007-04       Impact factor: 3.420

4.  Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.

Authors:  Edward C Stack; Karen M Smith; Hoon Ryu; Kerry Cormier; Minghua Chen; Sean W Hagerty; Steven J Del Signore; Merit E Cudkowicz; Robert M Friedlander; Robert J Ferrante
Journal:  Biochim Biophys Acta       Date:  2005-12-05

5.  HEAT repeats in the Huntington's disease protein.

Authors:  M A Andrade; P Bork
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

Review 6.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Authors:  Yoon Seong Kim; Tong H Joh
Journal:  Exp Mol Med       Date:  2006-08-31       Impact factor: 8.718

7.  Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment.

Authors:  Flaviano Giorgini; Thomas Möller; Wanda Kwan; Daniel Zwilling; Jennifer L Wacker; Soyon Hong; Li-Chun L Tsai; Christine S Cheah; Robert Schwarcz; Paolo Guidetti; Paul J Muchowski
Journal:  J Biol Chem       Date:  2007-12-13       Impact factor: 5.157

Review 8.  The kynurenine pathway of tryptophan degradation as a drug target.

Authors:  Robert Schwarcz
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

9.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

10.  Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.

Authors:  Xiaofeng Gu; Véronique M André; Carlos Cepeda; Shi-Hua Li; Xiao-Jiang Li; Michael S Levine; X William Yang
Journal:  Mol Neurodegener       Date:  2007-04-30       Impact factor: 14.195

View more
  71 in total

1.  Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.

Authors:  Surekha Ramachandran; Sumathi Thangarajan
Journal:  Metab Brain Dis       Date:  2018-05-31       Impact factor: 3.584

Review 2.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

3.  High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.

Authors:  Seth A Ament; Jocelynn R Pearl; Andrea Grindeland; Jason St Claire; John C Earls; Marina Kovalenko; Tammy Gillis; Jayalakshmi Mysore; James F Gusella; Jong-Min Lee; Seung Kwak; David Howland; Min Young Lee; David Baxter; Kelsey Scherler; Kai Wang; Donald Geman; Jeffrey B Carroll; Marcy E MacDonald; George Carlson; Vanessa C Wheeler; Nathan D Price; Leroy E Hood
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

4.  Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial Cells.

Authors:  Seung-Hwan Kwon; Shi-Xun Ma; Sa-Ik Hong; Seok-Yong Lee; Choon-Gon Jang
Journal:  J Med Food       Date:  2015-04-21       Impact factor: 2.786

Review 5.  Ca(2+) signaling: an outlook on the characterization of Ca(2+) channels and their importance in cellular functions.

Authors:  Jordan Karlstad; Yuyang Sun; Brij B Singh
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.

Authors:  Danielle A Simmons; Nadia P Belichenko; Tao Yang; Christina Condon; Marie Monbureau; Mehrdad Shamloo; Deqiang Jing; Stephen M Massa; Frank M Longo
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

Review 7.  The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective.

Authors:  V Hugh Perry; Vincent O'Connor
Journal:  ASN Neuro       Date:  2010-10-14       Impact factor: 4.146

Review 8.  Inflammatory mediators as biomarkers in brain disorders.

Authors:  Domenico Nuzzo; Pasquale Picone; Luca Caruana; Sonya Vasto; Annalisa Barera; Calogero Caruso; Marta Di Carlo
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 9.  Potassium channel dysfunction in neurons and astrocytes in Huntington's disease.

Authors:  Xiao Zhang; Jie-Qing Wan; Xiao-Ping Tong
Journal:  CNS Neurosci Ther       Date:  2018-01-27       Impact factor: 5.243

10.  Pesticides, microglial NOX2, and Parkinson's disease.

Authors:  Thomas Taetzsch; Michelle L Block
Journal:  J Biochem Mol Toxicol       Date:  2013-01-24       Impact factor: 3.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.